Notice of Annual General Meeting & Explanatory Statement Anatara Lifesciences Limited ACN 145 239 872 To be held at: Virtually via a virtual online platform. Shareholders must register to receive the link (see Letter from the Chair and Section C). Accordingly, there will be no physical venue for...
Anatara Lifesciences: Notice of Annual General Meeting/Proxy Form
Filed with ASX · · 33 pages · English
Summary by 6ix AI
Anatara Lifesciences Ltd has filed a Notice of Annual General Meeting and Proxy Form for shareholders to participate in the upcoming meeting. The meeting will be held virtually, and shareholders are encouraged to vote by proxy if they cannot attend. Key resolutions include the adoption of the Remuneration Report, re-election of a director, and approval of an Employee Incentive Plan. Shareholders must register in advance to receive access to the virtual meeting platform.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Anatara Lifesciences Ltd on 6ix
Earlier from Anatara Lifesciences
- Appendix 4G & Corporate Governance Statement
- Annual Report to shareholders
- Quarterly Activities/Appendix 4C Cash Flow Report
- Date of 2026 Annual General Meeting
- Anatara receives $318,402 in R&D Tax Incentive for FY26
Later from Anatara Lifesciences
All Anatara Lifesciences news releasesFollow Anatara Lifesciences into a list and get an email when it puts out news.
Follow Anatara Lifesciences